Showing results (151-160 of 809) with videos related to

Sort By:
Pageof 81
Gene Therapy|August 5, 2000
Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivoN Tomita, R Morishita, S Tomita, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 23, 2000
Association of polymorphism in the promoter region of the apolipoprotein E gene with diastolic blood pressure in normotensive JapaneseT Katsuya, N Sato, T Asai, et al.
Circulation Research|August 7, 1999
Angiotensinogen gene-activating elements regulate blood pressure in the brainT Nishii, A Moriguchi, R Morishita, et al.
Life Sciences|February 24, 2001
Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertensionN Sato, T Katsuya, T Nakagawa, et al.
Journal of Atherosclerosis and Thrombosis|January 1, 1997
Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF systemR Morishita, M Aoki, S Nakamura, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1996
Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemiaY Nakata, T Katsuya, H Rakugi, et al.
The American Journal of Physiology|November 1, 1996
Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous systemK Yamada, A Moriguchi, R Morishita, et al.
Circulation|November 3, 1998
Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expressionR Morishita, S Yamada, K Yamamoto, et al.
Gene Therapy|February 1, 1997
Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted areaM Aoki, R Morishita, J Higaki, et al.
Diabetes|January 1, 1997
Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetesR Morishita, S Nakamura, Y Nakamura, et al.
Pageof 81